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2214-0247/Copyright ª 2014, TaiwanAbstract Radiotherapy (RT) plays a much more important role in the treatment of colorectal
cancer when it can be used to reduce the size of a tumor prior to the local excision of the can-
cer. In order to find other factors possibly related to radiosensitivity, we evaluated the rela-
tionships between circulating blood cell counts and RT effects. In 81 cases of rectal cancer,
we examined white blood cell and platelet counts, as well as hemoglobin (Hb) levels, prior
to RT, and also investigated their associations with the treatment response rate and with other
clinicopathological factors. The patients with anemia had significantly worse RT responses,
whereas patients with high white blood cell counts (7400/mL) showed better responses
(p < 0.001). Cancer patients with low Hb levels do not respond as well to RT as nonanemicBiomedical Sciences, National Sun Yat-Sen University, 70 Lienhai Road, Kaohsiung 804, Taiwan.
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172 H.-C. Liu et al.patients (pZ 0.018). In colorectal cancer patients, white blood cell counts and Hb levels have
a significant impact on the responsiveness to RT.
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Colorectal cancer (CRC) was the third most commonly
diagnosed cancer and the fourth most fatal cancer world-
wide in 2008.1 Recent studies have shown that preoperative
radiotherapy (RT) can lead to a reduction in tumor size in
CRC. However, in unresponsive cases, RT may have disad-
vantages, such as delaying surgery or immunosuppression.
Therefore, suitable selection of patients for preoperative
RT is important for improving the outcomes of those with
CRC.
Anemia is known to produce tumor hypoxia, which con-
fers radioresistance through the hypoxia-associated
reduction in free-radical production and consequent RT-
induced DNA damage.2 Previous studies have shown that
the survival rate at 5 years for patients with anemia was
22%. For nonanemic patients, however, the rate at 5 years
was 36%, a significant increase compared with anemic pa-
tients (p Z 0.0016).3
Previous research has shown that radiosensitivity de-
pends not only on the biological characteristics of tumor
cells but also on the tumor microenvironment.4 In our
study, we examined the laboratory data including white
blood cell (WBC) counts, Hb levels, and platelet counts
during RT and the post-RT period prior to the surgery, which
may reflect systemic responses against tumor cells
damaged by irradiation.Materials and methods
Selection of patient samples
Eighty-one patients with CRC received RT in the Cancer
Center at Kaohsiung Medical University Hospital from May
2005 to February 2009. Pre-RT blood cell counts as well as
other clinical and pathological parameters were available
in all 81 cases, therefore data from all 81 patients were
included in this study.Laboratory test results and other clinical data
collection
A pre-RT complete blood count, including WBC counts, Hb
levels, and platelet counts, was routinely determined in
peripheral venous samples. Blood test results for each pa-
tient were obtained from the laboratory information sys-
tem of the Kaohsiung Medical University Hospital. Detailed
clinicopathologic information was obtained from the med-
ical records system.Tumor response
The assessment of pathological tumor response to preop-
erative RT was based on a standardized tumor regression
grading (TRG), as described by Dworak et al.5 TRG was
determined by the amount of viable tumor versus fibrosis,
ranging from TRG 4 (no viable tumor cells detected) to TRG
0 (fibrosis completely absent). TRG 3 was defined as a
regression of more than 50% with fibrosis outgrowing the
tumor mass; TRG 2 was defined as a regression of less than
50%; and TRG 1 was basically defined as a morphologically
unaltered tumor mass. In this study, pathological tumor
response was defined as ranging between TRG 2 and TRG 4.
Statistical analysis
All statistical data were analyzed using the SPSS 18.0 soft-
ware program (SPSS Inc., Chicago, IL, USA). A two-sided
Pearson chi-square test was used to analyze the potential
correlation between the RT response and the clinicopath-
ological features of the study participants. A Student t test
was used to compare the distribution of pre-RT WBC counts
and Hb level between RT response and nonresponse cases.
A probability level of less than 0.05 was considered statis-
tically significant.Results
Clinicopathological features
Eighty-one CRC patients (50 men and 31 women) were
included in this study. The median age of the patients was
63.5 (range 34e88) years at the date of diagnosis. After
preoperative RT, 60 patients (70%) achieved a pathological
tumor response. These patients’ characteristics and clini-
copathological findings are listed in Table 1.
Relationship between WBC count, Hb level, and RT
response
The correlation between preoperative RT WBC count, Hb
level, and treatment response was analyzed. WBC counts
were divided into four groups according to the criteria
described by Shankar et al.6 When grouped by WBC count,
patients with higher WBC counts (7.4  103/mL) had
better treatment responses than those with lower ones
(<7.4  103/mL; p < 0.001), whereas those with higher Hb
levels (12 g/dL) had better treatment responses than
those with lower ones (<12 g/dL; p Z 0.018; Table 1).
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Fig. 1 shows the distribution of pre-RT WBC counts and Hb
level in responsive and nonresponsive patients, respec-
tively. The mean WBC count was significantly greater
among patients with an RT response than in nonresponse
cases (8.0  2.05 vs. 5.8  1.87  103/mL; p < 0.001). The
mean Hb level was significantly greater among patients
with an RT response than in nonresponse cases
(12.73  2.05 vs. 11.46  1.74 g/dL, p Z 0.013).Discussion
Adjuvant RT is considered the standard treatment for
advanced CRC. Recent studies have suggested that there is
an association between the radiosensitivity of the tumor
microenvironment.4,7 Grigiene and colleagues8 found that
the hemoglobin (Hb) level prior to the treatment was an
independent prognostic factor for overall survival, disease-
free survival, and local relapse-free survival for patients
treated with irradiation. We hypothesized that WBC counts
and Hb levels, which reflect patient conditions, may criti-
cally affect responsiveness to RT. In fact, our results show
that WBC counts and Hb levels are indeed correlated with
the RT responses.
Previous studies have suggested that clinical factors and
some molecular markersdsuch as the circumferential
extent of the tumor, the treatment interval betweenTable 1 Clinical and pathological factors in 81 patients
with colorectal cancer.
Variables Nonresponse
(n Z 21)
Response
(n Z 60)
p
Age (y) 62.2  14.0 63.9  10.7 0.580
Sex 0.985
Male 13 37
Female 8 23
TNM stage 0.667
I 3 7
II 1 9
III 15 38
IV 2 6
WBC (103/mL) <0.001*
5.3 9 4
5.4e6.2 4 5
6.3e7.3 5 16
7.4 3 35
Hemoglobin (g/dL) 0.018*
12.0 9 43
<12.0 12 17
Platelet (105/mL) 0.262
>4.0 2 2
1.5e4.0 17 56
<1.5 2 2
*p < 0.05 represents a statistically significant difference using
chi-square test.
TNM Z tumor, node, metastasis staging system; WBC Z white
blood cell.radiation and surgical resection,9 and the levels of
epidermal growth factor receptor,10,11 Ki-67,12,13 Bcl-2/
Bax,11,12 and vascular endothelial growth factor13dare
significantly correlated with clinical response. In the
future, we will try to combine these prognostic markers
with WBC counts and Hb level in order to enhance the
prediction to the RT responsiveness. Furthermore, toFigure 1 (A) Distribution of pre-RT WBC counts. The mean
WBC count is significantly greater among patients with an RT
response than in nonresponse cases (8.0  2.05 vs.
5.8  1.87  103/mL, p < 0.001). (B) Distribution of pre-
radiotherapy Hb level. The mean Hb level was significantly
greater among those patients with an RT response than in
nonresponse cases (12.73  2.05 vs. 11.46  1.74 g/dL,
p Z 0.013). *p < 0.05 represents a statistically significant
difference using the Student t test. Hb Z hemoglobin;
RT Z radiotherapy; WBC Z white blood cell.
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radioresistance, we will also apply the mouse model for
further investigation.
Conclusion
Our findings indicate that WBC counts and Hb levels have a
significant impact on radiosensitivity in patients with CRC.
In addition, a complete blood count is a routine examina-
tion, and so a given patient’s WBC count and possible
anemia can be easily assessed. Further studies with larger
sample sizes are needed to validate these findings.
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